Sanofi acquires Blueprint Medicines Corp, including rare disease medicine, expanding rare immunology portfolio.
From Yahoo Finance: 2025-06-02 08:12:00 Sanofi SA has agreed to acquire Blueprint Medicines Corporation, including the rare immunology disease medicine
